Back
Axsome Therapeutics, Inc. 10K Form
Sell
26
AXSM
Axsome Therapeutics, Inc.
Last Price:
$164.00
Seasonality Move:
14.95%
7 Day Trial
ALL ACCESS PASS
$
7
Key Filings
10K form not available
Receive AXSM News And Ratings
See the #1 stock for the next 7 days that we like better than AXSM
AXSM Financial Statistics
Sales & Book Value
| Annual Sales: | $638.5M |
|---|---|
| Cash Flow: | $-18.7M |
| Price / Cash Flow: | 0 |
| Annual Sales: | $1.74 |
| Price / Book: | 94.95 |
Profitability
| EPS (TTM): | -3.69430 |
|---|---|
| Net Income (TTM): | $-183.2M |
| Gross Margin: | $582M |
| Return on Equity: | -265.23% |
| Return on Assets: | -28.95% |
Axsome Therapeutics, Inc. Earnings Forecast
Key Axsome Therapeutics, Inc. Financial Ratios
-
The Gross Profit Margin over the past 6 years for AXSM is 91.14%.
-
The Selling, General & Administrative Expenses for AXSM have been equal to 0.00% of Gross Profit Margin.
-
The Research & Development expenses have been 28.63% of Revenue.
-
The Net Earning history of AXSM is -28.69% of Total Revenues.
-
Per Share Earnings over the last 13 years have been positive in 3 years.
Axsome Therapeutics, Inc. Stock Price Chart
Industry, Sector and Symbol
| Stock Exchange: | NASDAQ |
|---|---|
| Industry: | Pharmaceuticals |
| Sector: | Health Care |
| Current Symbol: | AXSM |
| CUSIP: | 05464T |
| Website: | axsome.com |
Debt
| Debt-to-Equity Ratio: | 2.47 |
|---|---|
| Current Ratio: | 1.55 |
| Quick Ratio: | 1.44 |
Price-to-Earnings
| Trailing P/E Ratio: | 0 |
|---|---|
| Forward P/E Ratio: | 28.45 |
AXSM Technical Analysis vs Fundamental Analysis
Sell
26
Axsome Therapeutics, Inc. (AXSM)
is a Sell
Is Axsome Therapeutics, Inc. a Buy or a Sell?
-
Axsome Therapeutics, Inc. stock is rated a SellThe current Axsome Therapeutics, Inc. [AXSM] share price is $163.89. The Score for AXSM is 26, which is 48% below its historic median score of 50, and infers higher risk than normal.